Streetbeat News

Regulatory

GSK

UBS released a note stating that the ACIP Working Group recommends a universal RSV vaccine for individuals aged 75 and older from GSK. However, there is no endorsement for ages 50-59 due to limited data, and the recommendation for ages 60-74 is only for those 'at risk'.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 5:38 pm

BLK

The U.S. Court of Appeals has reaffirmed a ruling that certain BlackRock advised closed-end funds violated the Investment Company Act of 1940.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 5:31 pm

PFE

Pfizer reports a 15% decrease in patient enrollment in its Phase 3 ulcerative colitis trial, with enrollment dropping from 912 to 772 patients. The trial is active but not recruiting, and the primary completion date has been revised to July 20, 2026.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 5:22 pm

CVS

GSK

MRNA

PFE

Moderna's stock is trading lower due to concerns over the declining efficacy of its RSV vaccine compared to competitors GSK and Pfizer. The CDC's Advisory Committee on Immunization Practice is set to review vaccine recommendations, and Moderna's data shows a significant drop in efficacy over time. GSK and Pfizer's vaccines have shown better long-term efficacy, with GSK securing a larger market share and Pfizer winning a major contract in the U.K.

Portfolio Pulse from Vandana Singh

June 26, 2024 | 4:54 pm

META

Meta Platforms Inc. (NASDAQ:META) faces backlash after users discovered changes to political content settings on Instagram and Threads. The settings, intended to limit political content recommendations, were found to reset upon app closure, causing user frustration. Meta acknowledged the issue and is working on a fix.

Portfolio Pulse from Franca Quarneti

June 26, 2024 | 4:53 pm

PRGO

SPY

The U.S. Supreme Court is expected to allow abortions in medical emergencies in Idaho, according to a Bloomberg reporter citing a copy of an opinion briefly posted on the court's website.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 4:50 pm

TVGN

Tevogen Bio has filed a registration statement on Form S-1 to register the issuance of previously disclosed shares of the company's common stock.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 4:49 pm

TEM

Tempus AI shares are trading higher after the company announced it received U.S. FDA 510(k) clearance for its Tempus ECG-AF device, which uses AI to help identify patients at increased risk of atrial fibrillation/flutter.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 4:46 pm

SPY

The New York Transit Authority has voted to indefinitely halt the Manhattan congestion pricing plan. This decision could have implications for various sectors, including transportation and urban development.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 4:42 pm

BABA

NTES

TCEHY

China's approval of 104 new video games, including titles from Tencent and Alibaba, has positively impacted the gaming industry. NetEase's stock rose by 2.91% following the news. The market has been recovering since Beijing resumed licensing video games in April 2022.

Portfolio Pulse from Anusuya Lahiri

June 26, 2024 | 4:41 pm